Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
Sell
49
RHCGF Quote, Financials, Valuation and Earnings
Last price:
$1.75
Seasonality move
:
-12.08%
Day range:
$1.75 - $1.75
52-week range:
$1.21 - $2.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.38x
P/B ratio:
0.29x
Volume:
--
Avg. volume:
850
1-year change:
-32.95%
Market cap:
$875M
Revenue:
$423.7M
EPS (TTM):
-$0.46
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
CVM
CEL-SCI Corp.
|
-- | -- | -- | -- | $42.50 |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
-- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RHCGF
Ryman Healthcare Ltd.
|
$1.75 | -- | $875M | -- | $0.00 | 0% | 3.38x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
CVM
CEL-SCI Corp.
|
$6.53 | $42.50 | $19.8M | -- | $0.00 | 0% | -- |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$23.00 | -- | $13.5B | 53.08x | $0.17 | 1.51% | 10.63x |
|
PFGTF
Pacific Edge Ltd.
|
$0.10 | -- | $101.5M | -- | $0.00 | 0% | 8.49x |
|
SMGRF
Summerset Group Holdings Ltd.
|
$7.20 | -- | $1.7B | 7.89x | $0.07 | 1.95% | 8.52x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RHCGF
Ryman Healthcare Ltd.
|
-- | 1.726 | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
CVM
CEL-SCI Corp.
|
58.65% | 1.679 | 143.38% | 0.32x |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
3.28% | 0.499 | -- | 1.14x |
|
PFGTF
Pacific Edge Ltd.
|
1.14% | -3.720 | -- | 2.82x |
|
SMGRF
Summerset Group Holdings Ltd.
|
36.6% | -0.055 | -- | 0.11x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
CVM
CEL-SCI Corp.
|
-$959K | -$5.5M | -123.39% | -266.61% | -- | -$3.9M |
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$299.7M | -$209.7M | 18.6% | 19.71% | 40.18% | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -69.68% | -72.02% | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | 5.8% | 12.83% | -- | -- |
Ryman Healthcare Ltd. vs. Competitors
-
Which has Higher Returns RHCGF or AROAF?
Aroa Biosurgery has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RHCGFRyman Healthcare Ltd.-- -- -- AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About RHCGF or AROAF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Aroa Biosurgery, analysts believe Ryman Healthcare Ltd. is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings RHCGFRyman Healthcare Ltd.0 0 0 AROAFAroa Biosurgery0 0 0 -
Is RHCGF or AROAF More Risky?
Ryman Healthcare Ltd. has a beta of 0.512, which suggesting that the stock is 48.843% less volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock RHCGF or AROAF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHCGF or AROAF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Aroa Biosurgery quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than Aroa Biosurgery's net income of --. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.38x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHCGFRyman Healthcare Ltd.3.38x -- -- -- AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns RHCGF or CVM?
CEL-SCI Corp. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat CEL-SCI Corp.'s return on equity of -266.61%.
Company Gross Margin Earnings Per Share Invested Capital RHCGFRyman Healthcare Ltd.-- -- -- CVMCEL-SCI Corp.-- -$1.36 $17M -
What do Analysts Say About RHCGF or CVM?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand CEL-SCI Corp. has an analysts' consensus of $42.50 which suggests that it could grow by 550.84%. Given that CEL-SCI Corp. has higher upside potential than Ryman Healthcare Ltd., analysts believe CEL-SCI Corp. is more attractive than Ryman Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RHCGFRyman Healthcare Ltd.0 0 0 CVMCEL-SCI Corp.1 0 0 -
Is RHCGF or CVM More Risky?
Ryman Healthcare Ltd. has a beta of 0.512, which suggesting that the stock is 48.843% less volatile than S&P 500. In comparison CEL-SCI Corp. has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.259%.
-
Which is a Better Dividend Stock RHCGF or CVM?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CEL-SCI Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. CEL-SCI Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHCGF or CVM?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than CEL-SCI Corp. quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than CEL-SCI Corp.'s net income of -$5.7M. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while CEL-SCI Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.38x versus -- for CEL-SCI Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHCGFRyman Healthcare Ltd.3.38x -- -- -- CVMCEL-SCI Corp.-- -- -- -$5.7M
-
Which has Higher Returns RHCGF or FSPKF?
Fisher & Paykel Healthcare Corp. Ltd. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of 29.46%. Ryman Healthcare Ltd.'s return on equity of -- beat Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71%.
Company Gross Margin Earnings Per Share Invested Capital RHCGFRyman Healthcare Ltd.-- -- -- FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B -
What do Analysts Say About RHCGF or FSPKF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Fisher & Paykel Healthcare Corp. Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Fisher & Paykel Healthcare Corp. Ltd., analysts believe Ryman Healthcare Ltd. is more attractive than Fisher & Paykel Healthcare Corp. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RHCGFRyman Healthcare Ltd.0 0 0 FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 -
Is RHCGF or FSPKF More Risky?
Ryman Healthcare Ltd. has a beta of 0.512, which suggesting that the stock is 48.843% less volatile than S&P 500. In comparison Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, suggesting its more volatile than the S&P 500 by 20.107%.
-
Which is a Better Dividend Stock RHCGF or FSPKF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fisher & Paykel Healthcare Corp. Ltd. offers a yield of 1.51% to investors and pays a quarterly dividend of $0.17 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd. pays out 77.61% of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RHCGF or FSPKF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues of $723.8M. Ryman Healthcare Ltd.'s net income of -- is lower than Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Fisher & Paykel Healthcare Corp. Ltd.'s PE ratio is 53.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.38x versus 10.63x for Fisher & Paykel Healthcare Corp. Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHCGFRyman Healthcare Ltd.3.38x -- -- -- FSPKFFisher & Paykel Healthcare Corp. Ltd.10.63x 53.08x $723.8M $213.2M
-
Which has Higher Returns RHCGF or PFGTF?
Pacific Edge Ltd. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat Pacific Edge Ltd.'s return on equity of -72.02%.
Company Gross Margin Earnings Per Share Invested Capital RHCGFRyman Healthcare Ltd.-- -- -- PFGTFPacific Edge Ltd.-- -- $15.1M -
What do Analysts Say About RHCGF or PFGTF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Pacific Edge Ltd., analysts believe Ryman Healthcare Ltd. is more attractive than Pacific Edge Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RHCGFRyman Healthcare Ltd.0 0 0 PFGTFPacific Edge Ltd.0 0 0 -
Is RHCGF or PFGTF More Risky?
Ryman Healthcare Ltd. has a beta of 0.512, which suggesting that the stock is 48.843% less volatile than S&P 500. In comparison Pacific Edge Ltd. has a beta of -3.301, suggesting its less volatile than the S&P 500 by 430.112%.
-
Which is a Better Dividend Stock RHCGF or PFGTF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pacific Edge Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Pacific Edge Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHCGF or PFGTF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Pacific Edge Ltd. quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than Pacific Edge Ltd.'s net income of --. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Pacific Edge Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.38x versus 8.49x for Pacific Edge Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHCGFRyman Healthcare Ltd.3.38x -- -- -- PFGTFPacific Edge Ltd.8.49x -- -- --
-
Which has Higher Returns RHCGF or SMGRF?
Summerset Group Holdings Ltd. has a net margin of -- compared to Ryman Healthcare Ltd.'s net margin of --. Ryman Healthcare Ltd.'s return on equity of -- beat Summerset Group Holdings Ltd.'s return on equity of 12.83%.
Company Gross Margin Earnings Per Share Invested Capital RHCGFRyman Healthcare Ltd.-- -- -- SMGRFSummerset Group Holdings Ltd.-- -- $2.6B -
What do Analysts Say About RHCGF or SMGRF?
Ryman Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Summerset Group Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Ryman Healthcare Ltd. has higher upside potential than Summerset Group Holdings Ltd., analysts believe Ryman Healthcare Ltd. is more attractive than Summerset Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings RHCGFRyman Healthcare Ltd.0 0 0 SMGRFSummerset Group Holdings Ltd.0 0 0 -
Is RHCGF or SMGRF More Risky?
Ryman Healthcare Ltd. has a beta of 0.512, which suggesting that the stock is 48.843% less volatile than S&P 500. In comparison Summerset Group Holdings Ltd. has a beta of -0.437, suggesting its less volatile than the S&P 500 by 143.654%.
-
Which is a Better Dividend Stock RHCGF or SMGRF?
Ryman Healthcare Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Summerset Group Holdings Ltd. offers a yield of 1.95% to investors and pays a quarterly dividend of $0.07 per share. Ryman Healthcare Ltd. pays -- of its earnings as a dividend. Summerset Group Holdings Ltd. pays out 16.94% of its earnings as a dividend. Summerset Group Holdings Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RHCGF or SMGRF?
Ryman Healthcare Ltd. quarterly revenues are --, which are smaller than Summerset Group Holdings Ltd. quarterly revenues of --. Ryman Healthcare Ltd.'s net income of -- is lower than Summerset Group Holdings Ltd.'s net income of --. Notably, Ryman Healthcare Ltd.'s price-to-earnings ratio is -- while Summerset Group Holdings Ltd.'s PE ratio is 7.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ryman Healthcare Ltd. is 3.38x versus 8.52x for Summerset Group Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHCGFRyman Healthcare Ltd.3.38x -- -- -- SMGRFSummerset Group Holdings Ltd.8.52x 7.89x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
61
PLAB alert for Dec 11
Photronics, Inc. [PLAB] is up 0.62% over the past day.
Buy
77
BRZE alert for Dec 11
Braze, Inc. [BRZE] is down 2.54% over the past day.
Buy
66
OLMA alert for Dec 11
Olema Pharmaceuticals, Inc. [OLMA] is up 8.25% over the past day.
